Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

1.6K
The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
1.6K
Patterns of Fever01:26

Patterns of Fever

4.8K
Before understanding the types and patterns of fever, it is essential to know its phases.
4.8K
Arboviral Encephalitis01:25

Arboviral Encephalitis

54
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
54
Types of Fever01:25

Types of Fever

1.7K
Fever can be triggered by several factors, including infections, nervous system disorders, certain cancers, blood diseases like leukemia, embolism, thrombosis, heatstroke, dehydration, surgical trauma, crushing injuries, and allergic reactions.
Here are the different types of fever:
1.7K
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

22
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
22
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

5.0K
Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
5.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Causes of fever in Tanzanian adults attending outpatient clinics: a prospective cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same author

A multidimensional approach to impulsivity in Parkinson's disease: measurement and structural invariance of the UPPS Impulsive Behaviour Scale.

Psychological medicine·2016
Same author

Neurobehavioral and self-awareness changes after traumatic brain injury: Towards new multidimensional approaches.

Annals of physical and rehabilitation medicine·2015
Same author

[Horizon 00].

Revue medicale suisse·2015
Same author

[Risk communication in travel medicine].

Revue medicale suisse·2015
Same author

[Acute schistosomiasis: lessons learned from a cohort of 42 exposed travelers].

Revue medicale suisse·2015
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

Revue medicale suisse·2026
Same journal

[Erythema multiforme : target deciphering].

Revue medicale suisse·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti
08:33

A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti

Published on: May 16, 2011

15.0K

[Yellow fever: new recommendations].

L Rochat, B Genton

    Revue Medicale Suisse
    |June 10, 2014
    PubMed
    Summary
    This summary is machine-generated.

    Yellow fever vaccination decisions involve disease risk, public health, and traveler factors. New WHO guidelines confirm one dose provides lifelong protection, simplifying travel medicine strategies.

    More Related Videos

    Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
    08:36

    Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

    Published on: November 1, 2018

    33.7K
    Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
    10:35

    Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus

    Published on: May 31, 2020

    2.9K

    Related Experiment Videos

    Last Updated: Apr 28, 2026

    A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti
    08:33

    A Protocol for Collecting and Staining Hemocytes from the Yellow Fever Mosquito Aedes aegypti

    Published on: May 16, 2011

    15.0K
    Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction
    08:36

    Measuring Dengue Virus RNA in the Culture Supernatant of Infected Cells by Real-time Quantitative Polymerase Chain Reaction

    Published on: November 1, 2018

    33.7K
    Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus
    10:35

    Vector Competence Analyses on Aedes aegypti Mosquitoes using Zika Virus

    Published on: May 31, 2020

    2.9K

    Area of Science:

    • Travel Medicine
    • Infectious Disease Epidemiology
    • Vaccinology

    Background:

    • Assessing the need for yellow fever vaccination presents challenges, balancing individual risk with broader public health concerns.
    • Public health considerations include preventing epidemics in endemic areas and avoiding virus introduction into regions with competent mosquito vectors.
    • Travelers' personal risk factors for severe or fatal adverse events following vaccination must also be evaluated.

    Observation:

    • The World Health Organization (WHO) has updated its recommendations for yellow fever vaccination.
    • The updated guidelines are based on the conclusion that a single dose of the vaccine confers lifelong immunity.
    • This article reviews common scenarios encountered in travel medicine practice to guide vaccination strategies.

    Findings:

    • One dose of the yellow fever vaccine provides durable, lifelong protection.
    • Updated WHO recommendations simplify the approach to yellow fever immunization.

    Implications:

    • Travel medicine practitioners can adopt streamlined vaccination strategies based on new WHO guidelines.
    • The updated approach aims to optimize protection for travelers while considering individual risk factors and public health.
    • Clarifying these strategies is crucial for effective prevention of yellow fever transmission in 2013 and beyond.